Fisher & Paykel Healthcare Corporation Limited logo

FPH releases F&P Visairo hospital under-nose mask for NIV

Operational Update17 November 2021FPHHealthcare

News Release
STOCK EXCHANGE LISTINGS: NEW ZEALAND (FPH), AUSTRALIA (FPH)


Fisher & Paykel Healthcare releases F&P Visairo

™ hospital under-nose mask for

noninvasive ventilation


Auckland, New Zealand, 17 November 2021 – Fisher & Paykel Healthcare has announced the

launch of F&P Visairo™, a hospital under-nose mask for noninvasive ventilation, in the United

States.


F&P Visairo is a new high-performance under-nose hospital mask with dynamic support

technology. This allows for bridge-free noninvasive ventilation, which eliminates pressure from

the bridge of the nose and clears the way for an open field of vision, without compromising on

stability and performance. Stability wings in the mask frame provide support for the floating seal

to remain comfortable and stable on the patient’s face.


In trials of F&P Visairo, 96 percent of clinicians rated the mask ‘very good’ or ‘good’ for

performance, and 95 percent rated it ‘very good’ or ‘good’ for comfort.

1


“The feedback we have received from clinicians has been impressive,” said Dr Andrew

Somervell, VP Products and Technology for Fisher & Paykel Healthcare.


“For hospital patients who require higher levels of respiratory support without intubation, Visairo

provides a more comfortable experience, so the therapy is more likely to be effective. It sits

comfortably on the face and allows for a clear field of vision, so patients can wear glasses, read

or watch television during their treatment,” said Dr Somervell.


F&P Visairo is currently available in the U.S., New Zealand, Australia, and Europe and will be

released to other regions upon receiving regulatory clearances. The mask is available in three

sizes to correspond to the dimensions of the patient’s nose. Details can be found at

www.fphcare.com/visairo or by contacting your local Fisher & Paykel Healthcare sales

representative.


1

Clinicians' responses were collected at 12 different hospitals in the U.S., Canada and Australia. Data was gathered from at

least 93 responses.




About Fisher & Paykel Healthcare

Fisher & Paykel Healthcare is a leading designer, manufacturer and marketer of products and


systems for use in acute and chronic respiratory care, surgery and the treatment of obstructive

sleep apnea. The company’s products are sold in over 120 countries worldwide. For more

information about the company, visit our website www.fphcare.com

.


Authorised by Fisher & Paykel Healthcare Corporation Limited’s Company Secretary.


Media & Investor Contacts:

Karen Knott

GM Corporate Communications

karen.knott@fphcare.co.nz

+64 21 713 911

Hayden Brown

Investor Relations Manager

hayden.brown@fphcare.co.nz

+64 27 807 8073

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.

Other issuers discussed similar conditions around this time

Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.